Cyclosporin A (CSA) causes an acute vasoconstriction of hind limb arterial vessels. To determine the mechanism of action of CSA on the peripheral arterial bed, studies were performed on the isolated femoral artery perfused at constant flow in 
In rats5 and dogs6 treated with CSA, previous studies using radiolabeled microspheres showed a decrease in sympathetic stimulation * neuronal norepinephrine regional blood flows, except in the skeletal muscle, the liver, and the brain. In the human, an increase in sympathetic nervous activity was found.7 It has been suggested that the vascular effect of CSA may be mediated through a central cerebral action or a stimulation of the carotid chemoreceptors, resulting in an increase in sympathetic activity, or through a potentiation of the peripheral effect of norepinephrine (NE).8
The goal of the present study was to evaluate the effect and mechanism of action of CSA on peripheral arterial vessels in the isolated hind limb, the possible role of cerebral and reflex mechanisms in the response, and the influence of CSA on neuronal reuptake of NE.
Materials and Methods
Sixty-one mongrel dogs weighing [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] In six dogs, injections of four different doses of CSA (1, 5, 10 , and 20 mg) in the femoral artery inflow of the perfused hind limb were performed. The effect of systemic injections of CSA in the contralateral femoral vein at doses of 20 mg was studied in six dogs. In another group of six dogs, the effect of blockade of a-adrenergic receptors with an infusion of 10 mg phentolamine was evaluated. NE was given at a dose of 3 ,ug before and after phentolamine to test for the completeness of a-adrenergic blockade. A left lumbar sympathectomy was performed in six dogs by surgical dissection of the left lumbar sympathetic trunk, which was interrupted at the level of L-2, and the rami from L-2 to L-4 were cut.
Typically, hind limb perfusion pressure reached a plateau 5-9 minutes after the beginning of CSA injecthe injection. This plateau was taken as the maximal effect of the drug on hind limb vessels.
To study the central and reflex response to CSA, seven dogs were submitted to the same protocol described previously under thiopental (15 mg/kg) and chloralose (60 mg/kg) anesthesia to minimize the depressing effect. Additional doses of a-chloralose (10 mg/kg) were administered hourly. The right carotid chemoreceptors and baroreceptors were denervated by sinus nerve section achieved after ligation of the occipital artery at its origin from the external carotid artery and by careful dissection and removal of the immediate adjacent tissues. The left carotid bifurcation was left intact. To eliminate the effects of intrathoracic receptors,10 a bilateral cervical vagotomy was performed, and the animals were paralyzed with a neuromuscular blocking agent (pancuronium bromide, 0.1 mg/kg) to prevent the ventilatory response to chemoreceptor activation.
The integrity of the left carotid baroreceptors and chemoreceptors and the efficacy of the right carotid sinus nerve section were assessed with carotid occlusions (30 seconds) and injections of nicotine (0.1 ,g/ kg), a potent carotid chemoreceptor stimulant,11"12 into the common carotid arteries. Arterial blood gases and pH in systemic and reinjected autologous blood were carefully kept within the physiological range throughout the course of the experiment to prevent chemoreceptor activation by hypoxia, hypercapnia, or acidosis.13 Bolus injections of 10 ml autologous blood through catheters in the denervated right carotid artery and in the intact left common carotid artery were followed by injections of 20 mg pure powder CSA dissolved in 20 ml autologous blood. The left carotid sinus pressure was measured through a catheter in the external carotid artery, and variations in pressure never exceeded 5 mm Hg during the experiment. Blood samples were obtained from the right and left superficial jugular veins to determine CSA serum levels.
The effect of intrathoracic receptor stimulation by CSA was studied with bolus injections of 20 mg pure powder CSA diluted in 20 ml autologous blood directly into the right atrium in six animals with vagal and sinus nerves left intact. Fluoroscopic control was used to position the infusion catheter in the right atrium before infusion.
In 10 dogs, the effect of CSA on the vascular response to NE was studied after a left lumbar sympathectomy. NE was first injected at doses of 1, 2, and 4 ,g in the femoral arterial perfusion inflow before CSA administration. NE injections were repeated after systemic injections of 40 mg pure powder CSA dissolved into 120 ml autologous blood infused over a 20-minute period. Between each NE injection, hind limb perfusion pressure was allowed to return to the control level.
Neuronal NE recapture was studied with injections of tyramine, a sympathomimetic drug, which acts after uptake into the adrenergic nerve terminal and displacement of NE from the nerve endings. Injections of tyramine (50 ,ug/kg) were performed in 10 dogs. An initial control injection was followed by a second bolus of tyramine injected during CSA infusion (40 mg pure powder CSA dissolved in 120 ml blood infused over a 20-minute period). Tyramine was not injected until several minutes had elapsed and hind limb perfusion tion and persisted 5 minutes or more after the end of pressure after the beginning of CSA infusion had stabi-lized. In four experiments, phenylephrine (3 jig) was also injected before and during CSA infusion. In six of those dogs, tyramine (50 ,ug/kg) was injected before and after the administration of desmethylimipramine, a drug causing long-lasting inhibition of the carrier responsible for the transport of NE.14,15 In four experiments, the effect of three consecutive injections of tyramine was studied. Finally, in another group of four dogs, CSA (20 mg) was injected before and after the administration of desmethylimipramine.
The data are presented as mean+SEM changes in hind limb perfusion pressure and 95% confidence interval (CI). CSA Table 2 ). CSA blood level in the femoral vein at the end of injection averaged 489+±48 nmol/l. The decrease in the response to tyramine was not the result of an increase in the baseline perfusion pressure caused by CSA, since pressure increases caused by phenylephrine injections before (69+14 mm Hg) and during (63 +9 mm Hg) CSA injection in four experiments were similar (p>0.05).
On the other hand, the decreased response to tyramine with CSA was not the result of a tachyphylactic effect, since three consecutive injections of tyramine in four dogs resulted in similar increases in perfusion pressure (44 + 12, 45 ± 15, and 39 ± 9 mm Hg; p > 0.05).
Finally, no significant increase in perfusion pressure was obtained with tyramine (0±2 mm Hg) or with CSA (5±6 mm Hg, p>0.05) injections after tyramine carrier blockade with desmethylimipramine. Discussion Clinical1617 and experimental18-20 studies have shown a vasoconstrictive effect of CSA on renal arterial vessels. This vascular effect is probably responsible for the acute and chronic renal insufficiency and possibly for the hypertension observed after transplantation in patients treated with CSA immunosuppression. 21 The decrease in blood flow is not confined to the renal circulation, The ability of CSA to potentiate the response to NE could be explained either by an increase in adrenergic neurotransmission with CSA, by a direct effect of CSA on smooth muscle cells, or both. Enhanced adrenergic activation could result from such mechanisms as inhibition of recapture of NE or modulation of presynaptic receptors. CSA therapy in human does not decrease presynaptic a2-adrenergic receptors, which prevents further release of NE from sympathetic nerves. 28 On the other hand, if NE reuptake is inhibited, increased NE concentration at the postsynaptic site could be at least partly responsible for the increase in vascular resistance. In the present study, this mechanism was studied using tyramine, which enters the nerve endings through the NE carrier1429 and acts indirectly by stoichiometric displacement of NE from storage sites in the synaptic vesicle or from extravesicular binding sites.14,15,3031 Conversely, the effect of tyramine is abolished by drugs such as desmethylimipramine, which inhibits the NE transport system. 15 Our results suggest that CSA has an effect similar to that of desmethylimipramine, as shown by the marked decrease in the vascular response to tyramine with CSA infusion. Thus, a decrease in NE neuronal reuptake due to CSA could at least partly explain the increase in vascular resistance observed during CSA infusion. On the contrary, the response to phenylephrine remained unaltered after CSA infusion. Since this drug is not taken up into nerve endings, it also supports our hypothesis that CSA blocks NE uptake. The effect of CSA on NE uptake demonstrated in peripheral nerve endings of vascular smooth muscle cells may also occur centrally, since exocytosis and NE carrier-mediated processes operate in central nerve terminals as well. 15 Reports of increased sympathetic nerve discharges in humans7 and in animals8,25,32 under CSA therapy would support this hypothesis.
Thus, in the dog, CSA causes an increase in hind limb vascular resistance at serum levels within the therapeutic range used in clinical transplantation. This response is dependent on the sympathetic nervous system and adrenergic receptors but does not result from central or reflex stimulation. CSA causes a significant potentiation of NE vasoconstriction, which appears to be due to inhibition of NE reuptake at peripheral nerve endings, which could at least partly explain the adrenergic response to CSA.
